Ontralfy is a brand name for the antidepressant fluoxetine (often marketed under the generic name fluoxetine or the well‑known brand Prozac in many countries). It belongs to the class of drugs known as selective serotonin reuptake inhibitors (SSRIs). Below is an overview of its uses, how it works, dosing, side‑effects, and key safety information.
---
What is Ontralfy used for?
| Condition | Typical indication |
|-----------|--------------------|
| Major Depressive Disorder | Treat depression in adults and adolescents (≥12 yrs). |
| Panic Disorder | Reduce panic attacks and associated anxiety. |
| Obsessive‑Compulsive Disorder (OCD) | Decrease compulsions and intrusive thoughts. |
| Bulimia Nervosa | Reduce binge‑purging cycles (usually in combination with therapy). |
| Seasonal Affective Disorder | Mood improvement in winter months. |
Note: The drug can be used for other off‑label indications such as social anxiety disorder or pre‑menstrual dysphoric disorder, but these uses are less common.
---
How does it work?
Fluoxetine blocks the reuptake of serotonin (5‑HT) in the brain, increasing its concentration in the synaptic cleft. By enhancing serotonin transmission, it helps regulate mood, anxiety, and appetite.
Key pharmacology points:
- Half‑life: ~4–6 days (longer than most SSRIs) → steady‑state levels take 4–6 weeks.
- Metabolism: Primarily hepatic via CYP2D6; interactions with strong inhibitors/inducers of this enzyme are important.
- Withdrawal: Because of the long half‑life, discontinuation is usually smoother, but a gradual taper is still recommended to avoid discontinuation syndrome.
---
Typical dosing
| Population | Starting dose | Titration | Maintenance dose |
|------------|---------------|-----------|------------------|
| Adults | 20 mg once daily (sometimes 10 mg) | Increase by 10 mg every 1–2 weeks if needed | 20–40 mg (max 60 mg) |
| Adolescents (≥12 yrs) | 20 mg once daily | Similar titration | 20–40 mg |
| Elderly | Start 10 mg once daily (if comorbidities, renal/hepatic disease) | Titrate slowly | 10–20 mg |
Take with food to reduce stomach upset.
Do not abruptly stop the medication; taper over 4–6 weeks under a clinician’s supervision.
---
Common side‑effects
| Symptom | Frequency | Tips |
|---------|-----------|------|
| Nausea | 10–15 % | Take with meals; anti‑emetics if needed |
| Insomnia / vivid dreams | 10–15 % | Take in the morning or early afternoon |
| Sexual dysfunction (decreased libido, delayed orgasm) | 15–25 % | Discuss with provider; consider dose reduction or adjunct therapy |
| Headache | 10–15 % | Hydration, NSAIDs if needed |
| Diarrhea / GI upset | 10–15 % | Oral rehydration, loperamide if necessary |
| Dry mouth | 5–10 % | Sip water, use sugar‑free gum |
Most side‑effects are mild and tend to improve within a few weeks. If you experience severe or persistent symptoms, contact your prescriber.
---
Serious but less common risks
- Serotonin syndrome: symptoms include agitation, tremor, hyperreflexia, high fever, confusion. Occurs if combined with other serotonergic drugs (e.g., other antidepressants, tramadol, linezolid, triptans). Seek emergency care if suspected.
- Suicidal thoughts / behavior: especially in children, adolescents, and young adults (<25 yrs). Monitor closely for mood changes, agitation, or self‑harm urges.
- Hyponatremia (especially in older adults or those on diuretics).
- Bleeding risk: Fluoxetine can inhibit platelet aggregation; caution in patients on anticoagulants (warfarin, aspirin) or with bleeding disorders.
- Drug interactions: see “Drug interactions” below.
---
Drug interactions
| Interaction | Effect | What to do |
|-------------|--------|------------|
| MAO inhibitors (MAO‑I) | Serotonin syndrome | Avoid. If switching, wait ≥14 days after MAO‑I and 5 days after fluoxetine. |
| Other SSRIs/SNRIs | Increased serotonin, risk of syndrome | Avoid combining unless under strict monitoring. |
| Triptans (sumatriptan, rizatriptan) | Serotonin syndrome | Use with caution. |
| Linezolid (antibiotic) | Serotonin syndrome | Avoid concurrent use. |
| NSAIDs, aspirin, warfarin | ↑ bleeding risk | Monitor INR; consider platelet function tests. |
| CYP2D6 inhibitors (e.g., fluoxetine itself, paroxetine, quinidine) | ↑ fluoxetine levels | May need dose adjustment. |
| CYP2D6 inducers (e.g., rifampin, carbamazepine) | ↓ fluoxetine levels | May require higher dose; monitor response. |
| Alcohol | ↑ sedation, risk of suicidal thoughts | Limit alcohol intake. |
| Other serotonergic drugs (e.g., St. John’s Wort) | ↑ serotonin | Avoid. |
Always inform your prescriber of all medications, supplements, and herbal products you take.
---
Contraindications / Precautions
- Known hypersensitivity to fluoxetine or any excipient.
- Concurrent MAO‑I therapy (or within 14 days after discontinuation).
- Severe hepatic impairment – may require lower dose or avoidance.
- Pregnancy – category C; potential risk to fetus; discuss benefits vs. risks with a clinician.
- Breastfeeding – some secretion into milk; discuss with provider.
- Severe cardiovascular disease – rare, but monitor if present.
---
Pregnancy / Lactation
| Pregnancy | Breastfeeding |
|-----------|---------------|
| Pregnancy category: C (animal studies show fetal harm; no adequate human studies). Use only if benefits outweigh risks. | Breastfeeding: Fluoxetine is excreted into breast milk. The amount is generally low, but infants can be sensitive. Discuss with healthcare provider; weigh potential benefits to the mother against possible effects on the infant. |
---
Special Populations
- Elderly: Lower starting dose (10 mg) because of increased sensitivity, potential for falls, and comorbidities.
- **Ren